This compound is a benzodiazepine derivative used as an active pharmaceutical ingredient. It is structurally characterized as a 1,4-benzodiazepine with chloro and fluorophenyl substituents, and is supplied as a reference standard or impurity for pharmaceutical manufacturing and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Nitrous oxide
pharmaceutical raw material
Irinotecan hydrochloride
pharmaceutical raw material
Milrinone lactate
pharmaceutical raw material
Ferrous succinate
pharmaceutical raw material
1-demethyl-4,5-dihydrodiazepam
pharmaceutical raw material
7-chloro-1-[2-(ethylamino)ethyl]-5-(2-fluorophenyl)-4,5-dihydro-3H-1,4-benzodiazepin-2-one
UPMOXLUBWYXKHO-UHFFFAOYSA-N
CCNCCN1C(=O)CNC(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.